Budget 2023Budget 2023


  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
you are here: HomeNewsIndia
Live now
auto refresh
January 30, 2021 / 07:14 AM IST

Coronavirus News Highlights: Vaccination for frontline workers will start from 1st week of February 2021: Government Official

Coronavirus News LIVE Updates: More than 28 lakh people in India have received the first dose of the COVID-19 vaccine so far

Coronavirus News Highlights: Today is the 311th day since India implemented a nationwide lockdown to help curb the novel coronavirus pandemic. So far, India has recorded 1,07,01,193 confirmed COVID-19 cases, including 1,53,847 deaths. A total of 1,03,73,606 people have recuperated from COVID-19 so far. There are 1,73,740 active cases in the country as of date, which comprises 1.62 percent of the total caseload, the data stated. India's recovery rate continues to rise and now

stands at 96.94 percent. Globally, more than 10 crore people have been infected by the novel coronavirus and 21.88 lakh have died so far. Many countries, including India, have granted emergency use authorization for COVID-19 vaccines and have started vaccinating healthcare workers and high-risk groups. India's regulator has granted restricted emergency use approval for two vaccines -- Covishield and Covaxin. Over 23 lakh people have been given their first dose of the COVID-19 vaccine in India so far.

  • Coronavirus News Highlights: Vaccination for frontline workers will start from 1st week of February 2021: Government Official
    Residents wear face masks as they walk at a wet market at Jordan residential area in Hong Kong, China. (Image: Reuters)
    • 07:08 AM IST

      Over 20,000 private healthcare personnel get COVID-19 vaccine in Telangana

  • January 29, 2021 / 07:55 PM IST

    Coronavirus LIVE Updates | UNICEF chief sees H1 "crush" in COVID-19 vaccine demand easing in H2

    The U.N. Children’s Fund, the largest single buyer of vaccines in the world, expects a “crush” of demand for COVID-19 vaccines in the first year, with supplies only loosening in the second half, UNICEF executive director Henrietta Fore said on Friday. Fore, speaking to an event organised by the World Economic Forum, said: “What has happened in our world is that we now have a crush of demand here in the first half of the year and yet what it looks like from a manufacturing and availability point of view is that it’s the second half of the year when we are going to have the supply available. So timing is a big problem and a big issue but it gives us time to plan.” Sultan Ahmed bin Sulayem, chairman and ceo of DP World which signed a partnership with UNICEF earlier this week, said that demand for shipping goods was creating a shortage of empty containers in the market.

  • January 29, 2021 / 07:40 PM IST

    Coronavirus in Manipur LIVE Updates | Manipur reported 15 new COVID-19 cases and 25 recoveries today, says State Health Department. Total cases so far: 29,037, Total recoveries: 28,524, Active cases: 142, Total Deaths: 371, Recovery rate is 98.23 %.

  • January 29, 2021 / 07:22 PM IST

    Coronavirus in Rajasthan LIVE Updates | Rajasthan reports 103 new COVID-19 cases, 265 recoveries, and 2 deaths today. Total cases: 3,17,292, Total recoveries: 3,12,132, Death toll: 2,765, Active cases: 2,395.

  • January 29, 2021 / 07:20 PM IST

    Coronavirus in Karnataka LIVE Updates | Karnataka reports 468 new COVID-19 cases, 607 discharges, and 2 deaths in the last 24 hours, as per State Health Department. Total cases: 9,38,401, Active cases: 6,061, Total discharges: 9,20,110, Death toll: 12,211.

  • January 29, 2021 / 07:19 PM IST

    Coronavirus LIVE Updates | Government Official: Vaccination for frontline workers will start from 1st week of February 2021.

  • January 29, 2021 / 07:15 PM IST

    Coronavirus LIVE Updates | Johnson & Johnson 1-dose shot prevents COVID-19, but less than some others

    Johnson & Johnson’s long-awaited vaccine appears to protect against COVID-19 with just one shot – not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses. J&J said Friday that in the U.S. and seven other countries, the single-shot vaccine was 66% effective overall at preventing moderate to severe illness, and much more protective — 85% — against the most serious symptoms.

    Read more here

  • January 29, 2021 / 07:03 PM IST

    Coronavirus in Punjab LIVE Updates | Punjab School Education Minister Vijay Inder Singla says pre-primary classes at govt, private schools will restart from February 1.

  • January 29, 2021 / 07:02 PM IST

    Coronavirus LIVE Updates | Man dies hours after being administered coronavirus vaccine in UP's Pilibhit district; chief medical officer attributes it to heart ailment citing autopsy report

  • January 29, 2021 / 06:48 PM IST

    Coronavirus LIVE Updates | Karnataka govt appeals to Centre to treat teachers as frontline workers, include them in COVID-19 vaccination drive for priority sector.

  • January 29, 2021 / 06:33 PM IST

    Coronavirus LIVE Updates | Swiss Drugmaker Novartis To Help Make Pfizer-Biontech COVID-19 Vaccine

    Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech’s COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand. Subject to reaching a final agreement, Novartis plans to commence production in the second quarter of 2021, the Basel-based company said on Friday, adding it would use manufacturing facilities at its site in Stein, Switzerland, near the Rhine River on the German border. Three vaccines from Western companies Pfizer-Biontech, AstraZeneca and Moderna have been approved by regulators, but limited production and delayed deliveries have hampered efforts to quickly vaccinate people most at risk for COVID-19. Novartis’s announcement that it was joining the push to remedy the shortfall follows a move by Sanofi this week to work with Biontech to supply 125 million doses of its mRNA vaccine to the European Union. “Novartis has been mobilizing on multiple fronts to support the global pandemic response,” said Steffen Lang, head of Novartis Technical Operations. Novartis, which did not give specifics on how much drug substance it would produce for Pfizer-Biontech if the deal goes through, added it is in “advanced discussions” with additional companies to take on production of mRNA, therapeutic protein and other raw materials for vaccines and therapeutics.

  • January 29, 2021 / 06:18 PM IST

    Coronavirus in Delhi LIVE Updates | Manish Sisodia: Colleges, diploma institutions in Delhi to reopen from February 5.